Open access
Oct 2026
FORESEE: A prospective feasibility trial of functional precision oncology for metastatic breast cancer patients
The FORESEE trial (NCT04450706) was a prospective study to evaluate the feasibility of integrating organoid-based drug testing with comprehensive genomic characterization to inform treatment selection in patients with HER2-negative metastatic breast cancer. The primary objective of the study was to determine the feasib...
C. Vaklavas, S. Buys, S. D. Scherer et al.
· medRxiv · 0 citations